Aptiv PLC has a consensus price target of $115.67 based on the ratings of 24 analysts. The high is $173 issued by Guggenheim on July 20, 2022. The low is $63 issued by Piper Sandler on June 26, 2024. The 3 most-recent analyst ratings were released by B of A Securities, JP Morgan, and Barclays on July 22, 2024, July 22, 2024, and July 16, 2024, respectively. With an average price target of $104.67 between B of A Securities, JP Morgan, and Barclays, there's an implied 49.52% upside for Aptiv PLC from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/22/2024 | Buy Now | 50% | B of A Securities | John Murphy | $115 → $105 | Maintains | Buy | Get Alert |
07/22/2024 | Buy Now | 48.57% | JP Morgan | Ryan Brinkman | $113 → $104 | Maintains | Overweight | Get Alert |
07/16/2024 | Buy Now | 50% | Barclays | Dan Levy | $110 → $105 | Maintains | Overweight | Get Alert |
07/15/2024 | Buy Now | 64.29% | Evercore ISI Group | Chris McNally | $125 → $115 | Maintains | Outperform | Get Alert |
07/12/2024 | Buy Now | 54.29% | Citigroup | Itay Michaeli | $128 → $108 | Maintains | Buy | Get Alert |
07/12/2024 | Buy Now | 18.57% | Baird | David Leiker | $90 → $83 | Maintains | Neutral | Get Alert |
07/10/2024 | Buy Now | 44.29% | Goldman Sachs | Mark Delaney | $118 → $101 | Maintains | Buy | Get Alert |
07/10/2024 | Buy Now | 41.43% | UBS | Joseph Spak | $107 → $99 | Maintains | Buy | Get Alert |
07/09/2024 | Buy Now | 107.14% | Oppenheimer | Colin Rusch | $145 → $145 | Maintains | Outperform | Get Alert |
06/26/2024 | Buy Now | -10% | Piper Sandler | Alexander Potter | $78 → $63 | Downgrade | Neutral → Underweight | Get Alert |
06/25/2024 | Buy Now | 17.14% | Wells Fargo | Colin Langan | $83 → $82 | Maintains | Equal-Weight | Get Alert |
05/08/2024 | Buy Now | 34.29% | Guggenheim | Ronald Jewsikow | $92 → $94 | Maintains | Buy | Get Alert |
05/07/2024 | Buy Now | 61.43% | JP Morgan | Ryan Brinkman | $109 → $113 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 107.14% | Oppenheimer | Colin Rusch | $148 → $145 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 28.57% | Baird | David Leiker | $86 → $90 | Maintains | Neutral | Get Alert |
04/22/2024 | Buy Now | 55.71% | JP Morgan | Ryan Brinkman | $110 → $109 | Maintains | Overweight | Get Alert |
04/17/2024 | Buy Now | 31.43% | Guggenheim | Ronald Jewsikow | $103 → $92 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 57.14% | Barclays | Dan Levy | $112 → $110 | Maintains | Overweight | Get Alert |
02/07/2024 | Buy Now | 5.71% | Morgan Stanley | Adam Jonas | $90 → $74 | Downgrade | Equal-Weight → Underweight | Get Alert |
02/02/2024 | Buy Now | 47.14% | Guggenheim | Ronald Jewsikow | $120 → $103 | Maintains | Buy | Get Alert |
02/01/2024 | Buy Now | 94.29% | Citigroup | Itay Michaeli | $150 → $136 | Maintains | Buy | Get Alert |
02/01/2024 | Buy Now | 12.86% | Piper Sandler | Alexander Potter | $80 → $79 | Maintains | Neutral | Get Alert |
02/01/2024 | Buy Now | 111.43% | Oppenheimer | Colin Rusch | $149 → $148 | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | 48.57% | RBC Capital | Tom Narayan | — | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | 20% | Wells Fargo | Colin Langan | $79 → $84 | Maintains | Equal-Weight | Get Alert |
01/25/2024 | Buy Now | 64.29% | JP Morgan | Ryan Brinkman | $135 → $115 | Maintains | Overweight | Get Alert |
01/03/2024 | Buy Now | 37.14% | Baird | David Leiker | $105 → $96 | Downgrade | Outperform → Neutral | Get Alert |
11/14/2023 | Buy Now | 28.57% | Morgan Stanley | Adam Jonas | $100 → $90 | Maintains | Equal-Weight | Get Alert |
11/06/2023 | Buy Now | 60% | Barclays | Dan Levy | $138 → $112 | Maintains | Overweight | Get Alert |
11/03/2023 | Buy Now | 61.43% | RBC Capital | Tom Narayan | $130 → $113 | Maintains | Outperform | Get Alert |
11/03/2023 | Buy Now | 14.29% | Piper Sandler | Alexander Potter | $82 → $80 | Upgrade | Underweight → Neutral | Get Alert |
10/19/2023 | Buy Now | 107.14% | JP Morgan | Ryan Brinkman | → $145 | Upgrade | Neutral → Overweight | Get Alert |
10/11/2023 | Buy Now | 122.86% | Citigroup | Itay Michaeli | $162 → $156 | Maintains | Buy | Get Alert |
10/10/2023 | Buy Now | 101.43% | UBS | Joseph Spak | $143 → $141 | Maintains | Buy | Get Alert |
10/09/2023 | Buy Now | 112.86% | Oppenheimer | Colin Rusch | → $149 | Reiterates | Outperform → Outperform | Get Alert |
10/03/2023 | Buy Now | 51.43% | Wells Fargo | Colin Langan | $112 → $106 | Maintains | Equal-Weight | Get Alert |
09/13/2023 | Buy Now | 104.29% | UBS | Joseph Spak | → $143 | Initiates | → Buy | Get Alert |
08/08/2023 | Buy Now | 75.71% | JP Morgan | Ryan Brinkman | $120 → $123 | Maintains | Neutral | Get Alert |
08/07/2023 | Buy Now | 97.14% | Barclays | Dan Levy | $135 → $138 | Maintains | Overweight | Get Alert |
08/04/2023 | Buy Now | 112.86% | Oppenheimer | Colin Rusch | $146 → $149 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 60% | Wells Fargo | Colin Langan | $108 → $112 | Maintains | Equal-Weight | Get Alert |
08/04/2023 | Buy Now | 85.71% | RBC Capital | Tom Narayan | $127 → $130 | Maintains | Outperform | Get Alert |
07/18/2023 | Buy Now | 121.43% | Citigroup | Itay Michaeli | $150 → $155 | Maintains | Buy | Get Alert |
07/10/2023 | Buy Now | 54.29% | Wells Fargo | Colin Langan | $100 → $108 | Maintains | Equal-Weight | Get Alert |
07/06/2023 | Buy Now | 100% | B of A Securities | John Murphy | $130 → $140 | Upgrade | Neutral → Buy | Get Alert |
06/08/2023 | Buy Now | 85.71% | Wolfe Research | Rod Lache | → $130 | Upgrade | Peer Perform → Outperform | Get Alert |
05/17/2023 | Buy Now | 97.14% | Guggenheim | Ronald Jewsikow | $152 → $138 | Maintains | Buy | Get Alert |
05/16/2023 | Buy Now | 42.86% | Morgan Stanley | Adam Jonas | $105 → $100 | Maintains | Equal-Weight | Get Alert |
05/08/2023 | Buy Now | 92.86% | Barclays | Dan Levy | $142 → $135 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | 114.29% | Citigroup | Itay Michaeli | $154 → $150 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | 81.43% | RBC Capital | Tom Narayan | $128 → $127 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | 78.57% | Raymond James | Brian Gesuale | $135 → $125 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | 42.86% | Wells Fargo | Colin Langan | $113 → $100 | Maintains | Equal-Weight | Get Alert |
05/05/2023 | Buy Now | 92.86% | Baird | Luke Junk | $141 → $135 | Maintains | Outperform | Get Alert |
04/17/2023 | Buy Now | 102.86% | Barclays | Dan Levy | $150 → $142 | Maintains | Overweight | Get Alert |
04/10/2023 | Buy Now | 61.43% | Wells Fargo | Colin Langan | $120 → $113 | Maintains | Equal-Weight | Get Alert |
03/20/2023 | Buy Now | 82.86% | RBC Capital | Tom Narayan | → $128 | Reiterates | → Outperform | Get Alert |
02/15/2023 | Buy Now | 105.71% | Cowen & Co. | Jeffrey Osborne | $134 → $144 | Maintains | Outperform | Get Alert |
02/15/2023 | Buy Now | 117.14% | Guggenheim | Ronald Jewsikow | $138 → $152 | Maintains | Buy | Get Alert |
02/15/2023 | Buy Now | 120% | Citigroup | Itay Michaeli | $138 → $154 | Maintains | Buy | Get Alert |
02/15/2023 | Buy Now | 71.43% | Wells Fargo | Colin Langan | $115 → $120 | Maintains | Equal-Weight | Get Alert |
02/15/2023 | Buy Now | 82.86% | RBC Capital | Tom Narayan | $126 → $128 | Maintains | Outperform | Get Alert |
02/15/2023 | Buy Now | 101.43% | Baird | Luke Junk | $135 → $141 | Maintains | Outperform | Get Alert |
02/15/2023 | Buy Now | 114.29% | Barclays | Dan Levy | → $150 | Initiates | → Overweight | Get Alert |
02/07/2023 | Buy Now | 97.14% | Citigroup | Itay Michaeli | $126 → $138 | Maintains | Buy | Get Alert |
02/06/2023 | Buy Now | 64.29% | Wells Fargo | Colin Langan | $104 → $115 | Maintains | Equal-Weight | Get Alert |
02/03/2023 | Buy Now | 91.43% | Cowen & Co. | Jeffrey Osborne | $122 → $134 | Maintains | Outperform | Get Alert |
02/03/2023 | Buy Now | 117.14% | Oppenheimer | Colin Rusch | $159 → $152 | Maintains | Outperform | Get Alert |
02/03/2023 | Buy Now | — | Wolfe Research | Rod Lache | — | Downgrade | Outperform → Peer Perform | Get Alert |
02/03/2023 | Buy Now | 92.86% | Raymond James | Brian Gesuale | $125 → $135 | Maintains | Outperform | Get Alert |
01/17/2023 | Buy Now | 48.57% | Wells Fargo | Colin Langan | $94 → $104 | Maintains | Equal-Weight | Get Alert |
01/09/2023 | Buy Now | 71.43% | B of A Securities | John Murphy | $151 → $120 | Downgrade | Buy → Neutral | Get Alert |
12/15/2022 | Buy Now | 64.29% | RBC Capital | Joseph Spak | $120 → $115 | Maintains | Outperform | Get Alert |
11/28/2022 | Buy Now | 50% | Morgan Stanley | Adam Jonas | $120 → $105 | Downgrade | Overweight → Equal-Weight | Get Alert |
11/04/2022 | Buy Now | 71.43% | RBC Capital | Joseph Spak | $125 → $120 | Maintains | Outperform | Get Alert |
11/04/2022 | Buy Now | 78.57% | Raymond James | Brian Gesuale | $145 → $125 | Maintains | Outperform | Get Alert |
09/28/2022 | Buy Now | 82.86% | Citigroup | Itay Michaeli | $150 → $128 | Maintains | Buy | Get Alert |
09/28/2022 | Buy Now | 85.71% | Berenberg | Jared Maymon | → $130 | Assumes | → Buy | Get Alert |
09/09/2022 | Buy Now | 125.71% | B of A Securities | John Murphy | $165 → $158 | Maintains | Buy | Get Alert |
08/11/2022 | Buy Now | 71.43% | Morgan Stanley | Adam Jonas | $149 → $120 | Maintains | Overweight | Get Alert |
08/08/2022 | Buy Now | 131.43% | Oppenheimer | Colin Rusch | $172 → $162 | Maintains | Outperform | Get Alert |
08/05/2022 | Buy Now | 88.57% | Deutsche Bank | Emmanuel Rosner | $136 → $132 | Maintains | Buy | Get Alert |
08/05/2022 | Buy Now | 107.14% | Raymond James | Brian Gesuale | $158 → $145 | Maintains | Outperform | Get Alert |
07/20/2022 | Buy Now | 147.14% | Guggenheim | Ali Faghri | $180 → $173 | Maintains | Buy | Get Alert |
07/18/2022 | Buy Now | 94.29% | Deutsche Bank | Emmanuel Rosner | $137 → $136 | Maintains | Buy | Get Alert |
07/14/2022 | Buy Now | 112.86% | Morgan Stanley | Adam Jonas | $155 → $149 | Maintains | Overweight | Get Alert |
07/11/2022 | Buy Now | 45.71% | Wells Fargo | Colin Langan | $112 → $102 | Maintains | Equal-Weight | Get Alert |
06/02/2022 | Buy Now | 121.43% | Morgan Stanley | Adam Jonas | $170 → $155 | Maintains | Overweight | Get Alert |
06/01/2022 | Buy Now | 92.86% | Goldman Sachs | Mark Delaney | $150 → $135 | Maintains | Buy | Get Alert |
05/09/2022 | Buy Now | 95.71% | Deutsche Bank | Emmanuel Rosner | $140 → $137 | Maintains | Buy | Get Alert |
05/06/2022 | Buy Now | 114.29% | Credit Suisse | Dan Levy | $160 → $150 | Maintains | Outperform | Get Alert |
05/06/2022 | Buy Now | 125.71% | Raymond James | Brian Gesuale | $215 → $158 | Maintains | Outperform | Get Alert |
04/21/2022 | Buy Now | 100% | Deutsche Bank | Emmanuel Rosner | $158 → $140 | Maintains | Buy | Get Alert |
04/18/2022 | Buy Now | 28.57% | Piper Sandler | Alexander Potter | $177 → $90 | Downgrade | Neutral → Underweight | Get Alert |
04/12/2022 | Buy Now | 60% | Wells Fargo | Colin Langan | $108 → $112 | Upgrade | Underweight → Equal-Weight | Get Alert |
04/07/2022 | Buy Now | 128.57% | Barclays | Brian Johnson | $184 → $160 | Maintains | Overweight | Get Alert |
04/06/2022 | Buy Now | 142.86% | Morgan Stanley | Adam Jonas | $200 → $170 | Maintains | Overweight | Get Alert |
04/06/2022 | Buy Now | 135.71% | B of A Securities | John Murphy | → $165 | Upgrade | Underperform → Buy | Get Alert |
04/01/2022 | Buy Now | 54.29% | Wells Fargo | Colin Langan | $114 → $108 | Maintains | Underweight | Get Alert |
03/22/2022 | Buy Now | 131.43% | Goldman Sachs | Mark Delaney | $189 → $162 | Maintains | Buy | Get Alert |
The latest price target for Aptiv (NYSE:APTV) was reported by B of A Securities on July 22, 2024. The analyst firm set a price target for $105.00 expecting APTV to rise to within 12 months (a possible 50.00% upside). 42 analyst firms have reported ratings in the last year.
The latest analyst rating for Aptiv (NYSE:APTV) was provided by B of A Securities, and Aptiv maintained their buy rating.
The last upgrade for Aptiv PLC happened on November 3, 2023 when Piper Sandler raised their price target to $80. Piper Sandler previously had an underweight for Aptiv PLC.
The last downgrade for Aptiv PLC happened on June 26, 2024 when Piper Sandler changed their price target from $78 to $63 for Aptiv PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aptiv, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aptiv was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
While ratings are subjective and will change, the latest Aptiv (APTV) rating was a maintained with a price target of $115.00 to $105.00. The current price Aptiv (APTV) is trading at is $70.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.